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Case presentation
A 33-year-old man was first examined at the age of 23 years. He was
admitted to the Universith Degli Studi di Napoli hospital because a
routine laboratory evaluation prior to an appendectomy had shown a
BUN of 55 mg/dl. His hearing had been impaired since birth, and he had
a 4-year history of polyuria and nocturia; macroscopic hematuria had
never been noted.
His father had died at age 54 of chronic cor pulmonale, and his
mother had diabetes mellitus. Of a total of 11 brothers, 9 were alive and
well; 2 had died in the first year of life of unknown causes. All family
members were of normal stature. There was no family history of
deafness.
On physical examination at age 23, the height was 154 cm and the
weight was 38 kg; there were no malformations. Blood pressure was
120/80 mm Hg. Funduscopic examination was normal. Cardiac exami-
nation revealed a precordial thrust and a grade 11/Vt apical systolic
murmur but was otherwise unremarkable. The testicles were well
formed but small. There were no neurologic deficits. The remainder of
the examination was unremarkable.
Urinalysis revealed the following: specific gravity, 1.009; pH, 5; 1+
protein; and 2 to 3 white blood cells per high-power field. The urine
culture was negative on three occasions. Other values included: BUN,
50 mg/dl; glucose, 80 mg/dl; hemoglobin, 13.5 g/dl; sodium, 139 mEqI
liter; potassium, 4.6 mEq/liter; bicarbonate, 18 mEq/liter; calcium, 9
mg/dl; and phosphorus, 4.4 mg/dl. Serum alkaline phosphatase was 40
mU/mI (normal <70 mU/mi); uric acid, 6 mg/dl; plasma proteins, 7.0 g/
dl (60% albumin); serum creatinine, 3 mg/dl; creatinine clearance, 28
mI/mm per 1.73 m2; triglycerides, 200 mg/dl, and cholesterol, 180 mg/dl.
An electrocardiogram showed mild left ventricular hypertrophy. A
chest x-ray revealed no cardiac abnormalities, but some calcified lymph
nodes were seen in the right mid-thoracic region. An audiogram
disclosed bilateral hearing deficits, more severe on the left. Renal
tomography revealed the left kidney to be 9 cm and the right kidney to
be 6 cm long. An intravenous pyelogram showed no obstruction.
A renal biopsy revealed changes consistent with membranoprolifera-
tive glomerulonephritis. Plasma essential amino acids were normal but
there were increased concentrations of I- and 3-methyl-histidine and
decreased concentrations of tyrosine and proline. The tyrosine/phenyl-
alanine ratio was reduced, but the ratio of the concentrations of
essential and nonessential amino acids was normal (Table I).
A low-protein diet providing 0.45 g/kg of high-quality protein was
prescribed. Emphasis was placed on egg yolk, cheese, rice, and shrimp.
with meat or whole egg as alternatives. The patient was allowed to
double his daily protein intake once a week. The energy content of the
diet of 188 kj/kg was derived mainly from carbohydrates: the ratio of
energy derived from carbohydrates to that from fats was 3:1. Vitamin
supplements were provided daily; phosphate binders were not used.
While the patient was ingesting this diet, nitrogen balance was positive
(Fig. 1).
The patient was seen bimonthly in the outpatient department. A
dietician visited him every 2 to 3 months to ensure adherence to the
prescribed diet. All reports suggested that the patient was complying
with the prescriptions and that his mother had been employing various
techniques to avoid dietary monotony. The diet was changed every
season so that the patient could have his usual foods as well as many
kinds of green vegetables. He also was given a dietary plan designed to
avoid his having to eat the same meal more than 4 times per month. The
patient worked as a barber and was completely asymptomatic.
Laboratory data 2 years after the initial hospital admission revealed
that the creatinine clearance was still 27 mI/mm. the serum creatinine
was 3.2 mg/dl, and the BUN was 20 mg/dl. When the patient was
examined 2 years later, the blood pressure was 140/80 mm Hg, the
creatinine clearance was 16 mI/mm, the BUN was 28 mg/dl, and the
serum creatinine was 6 mg/dl. At that time, his protein intake was
decreased to 0.38 g/kg body weight. Evaluation 2 years later (6 years
after his first evaluation) revealed a blood pressure of 140/80 mm Hg, a
BUN of 27 mg/dl, and a serum creatinine of 6.2 mg/dl.
The patient was rehospitalized 2 years later at age 31, 8 years after his
first admission. His blood pressure was 140/80 mm FIg and a funduscop-
ic examination was normal. The remainder of the physical examination
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did not differ from that of 8 years before. Laboratory findings on
admission included: hemoglobin, 11.5 g/dl; BUN, 35 mg/dl; serum
creatinine, 9.9 mg/dl; and creatinine clearance, 7.5 mI/mm. Results of
urinalysis revealed a specific gravity of 1.006, a p1-1 of 5, I + protein,
and unremarkable sediment. The 24-hour urine protein was 0.42 g. A
urine culture was sterile. Other laboratory values were: uric acid, 8.5
mg/dl; sodium, 130 mEq/liter; potassium, 4.4 mEq/liter; calcium, 9 mgI
dl; phosphorus, 4.4 mg/dl; and plasma protein, 7.1 gldl (60% albumin).
Results of renal tomography were unchanged from 8 years before. An
electrocardiogram showed left ventricular hypertrophy with strain. The
serum triglyceride level was 248 mg/dl; serum cholesterol, 184 mg/dl;
and serum glucose, 75 mg/dl. A chest x-ray illustrated that the cardiac
shadow was not enlarged.
Urea generation, measured using the technique developed by Walser
and Bodenlos [1], provided the following results: urea from the diet was
5.21 glday, and urea appearance was 4.7 g/day; thus, urea from the diet
minus the urea generated yielded 0.51 g/day.
A nitrogen balance study also was performed and again was positive
(Fig. 1). Measurement of plasma amino acid concentrations revealed a
reduction in some essential amino acids (threonine, valine, leucine)
(Table 1). Nonessential amino acids did not increase significantly with
time. All clinical features previously noted persisted. The patient was
discharged and was monitored as an outpatient every 15 days. Three
months after his hospitalization, the blood pressure was 140/100 mm
Hg, the serum creatinine was 9.1 mg/dl, and the BUN was 38 mg/dl. Six
months after his admission, the serum creatinine was 9.7 mg/dl, and the
BUN was 42 mg/dl. Two years after the second hospitalization (10 years
after his first admission), followup examination revealed a serum
creatinine level of 10.4 mg/dl and a BUN of 48 mg/dl. Four months
subsequently, laboratory evaluation revealed: hemoglobin, 10 g/dl;
serum glucose, 75 mg/dl; uric acid, 8.6 mg/dl; sodium, 140 mEq/liter;
potassium, 4.2 mEq/liter; bicarbonate, 14 mFq/liter: calcium, 9 mg/dl;
phosphorus, 5.2 mg/dl; alkaline phosphatase, 110 mU/mi; creatinine
13.7 mgldl; creatinine clearance, 3.90 mI/mm per 1.73 m2; and BUN, 55
mgldl. The weight was 42 kg and the blood pressure was 150/100 mm
Hg.
The patient had gained 4 kg over the 10 years of follow up, but he was
never edematous. Hemodialysis was started approximately 10 years
after initial evaluation.
Discussion
Da. CARMELO GIORDANO (Professor and Chairman, Depart-
ment of Nephrology, University of Naples, Naples, Italy): I
would like to examine some of the aspects of renal dysfunction
in this patient and then devote the major part of my discussion
to one component of conservative therapy for chronic renal
failure and uremia: dietary management. There is no doubt that
this patient suffered from a form of progressive renal disease
that produced very few symptoms. The absence of hematuria,
family history, ocular manifestations and, more important, of
familial deafness are all features that prevent us from firmly
diagnosing Alport's syndrome, a hereditary form of renal
disease that can progress slowly. Because the patient had
normal plasma proline levels and no neurologic deficits, some
of the variants of Alport's syndrome also were ruled out.
Moreover, the absence of clubbing of the feet and of muscular
wasting excludes the possibility of Charcot-Marie-Tooth dis-
ease, which also can give rise to progressive renal disease. We
therefore concluded that this patient has chronic glomerulone-
phritis with progressive renal insufficiency and some degree
of somatic stunting (height, 154 cm). It is remarkable that he
was azotemic at age 22 and his creatinine clearance level was 28
mI/mm, but dialysis was not initiated until the patient was 33
years old. Throughout the exceptionally slow course of his
renal failure, a low-protein diet was the principal therapy
employed.
Even though dialysis has reached its 20th year of growing
success in the therapy of chronic uremia, and renal transplanta-
tion from cadaveric donors has provided evidence of improved
survival [21, several issues concerning diet and chronic uremia
remain to be clarified: Does a uremic patient need a special
diet? If so, why? Should the diet be instituted for a short time or
for years? What are the consequences of the prolonged use of
such a diet? Is there a specific benefit for the patient'?
Addis compared the dysfunctional kidney with the dysfunc-
tional heart [3]. A strong advocate of a low-protein diet, Addis
was convinced that normal protein intake, with its relatively
high urea load, is to the shrunken kidney what muscle exercise
is to the heart in failure. This comparison is not difficult to
accept, although concrete evidence now indicates that, in
patients with a normal protein intake, the most dangerous
aspect of uremia is the phosphate load [41 rather than the urea
load resulting from protein catabolism.
Supporting these purely empiric arguments, several studies
using laboratory animals have suggested that low-protein diets
are beneficial. Uremic rats survive longer when fed a low-
protein diet F5], and Farr and Smadel showed that nephrotic rats
recover if given a low-protein diet [6]. Although Naeraa did not
find any clinical difference in the course of glomerulonephritis
when patients were given either 125 or 40 g/day of protein, the
finding is irrelevant because the regimens were, respectively,
neither especially high nor especially low in protein content [7].
With the exception of the study by Kopple and colleagues [5],
all these experimental data refer to work performed around
1937 and 1938. Earlier work in basic science did, however,
Table 1. Plasma amino acid concentrations (mg/dl) at two times
during the patient's course
Threonine 1.44 0.18
Valine 2.50 0.21
Methionine 0.50 0.06
Leucine 1.61 0.06
Isoleucine 1.03 0.13
Phenylalanine 1.18 0.23
Lysine 2.19 + 0.27
Total EA 10.41 1.13
Glycine 1.94 0.30
Alanine 3.48 0.32
a-amino-butyric acid 0.30 0.12
Serine 1.49 0.11
Taurine 0.59 0.12
Asparagine 0.48 0.12
Ornithine 0.69 0.11
Aspartic acid 0.58 0.12
Glutamine 7.56 0.80
Glutamic acid 0.84 0.37
Histidine 1.32 0.08
I -methyl-histidine
3-methyl-histidine 0.14 0.06
Arginine 1.77 0.14
Tyrosine 1.42 0.06
Citrulline
Proline 2.15 0.75
Total NEAb 18.48 2.90
Tyrosine/phenylalanine 1.20 0.05
a EA refers to essential amino acids.
"NEA refers to nonessential amino acids.
Patient's values
Age 23 Age 31
0.87 0.63
1.92 1.32
0.48 0.55
1.54 1.14
1.19 1.43
1.24 1.41
3.00 2.82
10.34 9.00
2.00 2.27
2.35 2.67
0.43 0.51
1.43 1.68
1.82 1.73
1.22 1.10
1.51 1.37
0.42 0.29
5.37 6.22
1.44 1.35
t.40 1.36
0.42 0.55
0.84 1.03
1.30 1.28
0.80 0.75
0.35 0.42
0.35 0.51
23.47 25.10
0.44 0.35
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provide valuable information about nutritional therapy in renal
failure.
In 1923, F. M. Allen stressed the importance of rigid nitrogen
restriction in azotemic patients to Millard Smith, a biochemist
at the New England Deaconess Hospital in Boston. Dr. Allen
must have been very convincing, because Dr. Smith abandoned
his work in biochemistry to embark on what he perceived as a
fascinating field. Smith performed a meticulous experiment to
determine the minimum total urea nitrogen excretion in a
human. The experiment was performed on a medical student
given a high-caloric diet containing only carbohydrates and fats
for 24 days. The diet produced an intense nausea that could be
controlled using a low-nitrogen bread prepared from corn
starch, India gum, yeast, sugar, and salt. With the aid of some
vegetables and sweet beverages, Smith was able to give the
student, who weighed 65 kg, as much as 4000 calories a day.
The daily nitrogen intake was maintained at approximately 300
mg. Urinary nitrogen excretion fell from 14.25 g/24 hours on the
first day of the experiment to a minimum value of 1.58 g/24
hours on the 24th day. The study volunteer, in considering "his
extremely low nitrogen excretion of the day before," became so
alarmed that he decided he could continue the experiment no
longer [81. However, Smith continued his work and explored its
further clinical application, later maintaining an azotemic pa-
tient for 6 months on an average daily protein intake of 0.26 g/kg
body weight, that is, on an 18 g protein diet for a 70 kg patient
[9]. This excursion into history underscores several timely
issues: the feasability of a low-protein, high-caloric intake; the
utility of low-nitrogen, artificially prepared food; and the intol-
erance to such a regimen.
Let us try to define a nutritionally adequate, low-protein diet.
How low can the dietary protein content fall before malnutrition
is induced? Nutritional status partly depends on the quality of
the protein; the higher the biologic value of a protein, the less
the amount required for normal nutrition. Egg protein has the
highest biologic value; certain vegetables have the lowest. In a
well-designed study of 27 healthy adult men, Kofranyi and
Jekat found that 0.5 g of egg protein per kg body weight
represented the minimum requirement [10, II]. This level of
ingested high-biologic-value protein constitutes an important
benchmark for our discussion. But the same authors showed
that, of this amount of protein nitrogen, two-thirds could be
substituted by glutamic acid, aspartic acid, or ammonium
nitrogen without adverse effect. Thus, the absolute minimum
protein requirement in this study was 0.17 g/kg, that is, one-
third of 0.5 g/kg, provided that sufficient nitrogen in the form of
an ammonium salt was given. Because urea in the body can be
split by intestinal urease into two ammonium ions, it is theoreti-
cally possible for urea to provide the needed source of nitrogen
under these conditions.
This possibility is consistent with Snyderman's investigations
of urea nitrogen utilization in normal babies [12] and is substan-
tiated by our own findings regarding utilization of exogenous or
endogenous urea or ammonium nitrogen in normal and uremic
subjects [13—15]. We suggested that if urea were used for
synthesizing nonessential amino acids and thus protein, uremic
patients could reuse their own urea for anabolic purposes while
nitrogen intake is lowered below 0.5 g protein/kg or is confined
to only the essential amino acids. From these studies, the
concept emerges that a nutritionally adequate low-protein diet
could contain 0.5 g/kg body weight of high-biologic-value
protein or less than 0.5 g of protein if enough urea nitrogen were
available metabolically to reach the equivalent of 0.5 g/kg body
weight of protein.
According to this hypothesis, as the dietary protein content is
reduced toward 0.17 g/kg in azotemic patients, the utilization of
urea will increase. Thus, the amount of urea nitrogen reutilized
for protein synthesis in uremic patients could be either very
high or very low, depending on the level of protein intake. With
this in mind, it is possible to explain all the apparent discrepan-
cies in urea nitrogen utilization that have been reported in
uremia.
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Fig. 1. Serial observations of nitrogen balance,
blood pressure, body weight (in parentheses),
and creatinine clearance in the present patient.
Note that nitrogen balance was positive when
assessed at age 23 and again at age 31. Hemodi-
alysis (HD) was begun at age 33.
00Co
.5 C
S 10
0
I
120 120 120 120 120 12080 80 80 80 80 80
Diet—
(38) (38) (39) (40) (41.5) (42) (42)S S S Start HO
S • • •
S S..
S
S • •
23 25 27 29 31 33
Patient age, years
404 Nephrology Forum
Table 2. Recommended pattern of essential amino acids for dietary
use in patients with uremia
Amino acid
Threonine
Isoleucine
Leucine
Valine
Phenylalanine
Tyrosine
Methionine
Cystine
Tryptophan
Lysine
Histidine
Amount required daily (mg/kg
body weight)
1 19.5 39
1.3 25.3 50.7
1.8 35.1 70.2
1.5 29.2 58.5
0.7 13.6 27.3
1.2 23.4 46.8
0.4 7.8 15.6
0.4 7.8 15.6
0.24 4.7 9.4
1.1 21.4 42.9
0.5 9.7 19.5
During the last few years, at least three excellent papers have
examined the subject of dietary therapy in uremia and have
considered the problem of urea nitrogen reutilization [16—181.
All three reviewers concluded that the amount of urea nitrogen
reused for protein synthesis is negligible and thus without any
practical importance. This conclusion is derived, in large part,
from two studies deemed by Richards to be "rigorous and
independent" [19]. One of these investigations was that of
Varcoe and coworkers, who intended to study the rate of urea
utilization in a group of uremic patients ingesting low-protein
diets. Using a diet with 30 g of high-biologic-value protein, they
compared the results to those obtained from uremic patients
ingesting a normal (70 g) protein intake, and with normal
subjects ingesting either a 70 g or a 30 g protein diet [20, 211.
These were the intentions. On scrutinizing the data, however, it
is evident that the patients receiving 30 g of protein were in fact
not being given a low-protein diet at all; they were getting
approximately 0.6 g/kg body weight of protein, which is the
level recommended for normal nutrition [22]. Indeed, the "low-
protein diet" was supplying these 5 patients, respectively, with
0.64, 0.68, 0.60, 0.54, and 0.47 g/kg body weight of protein.
Moreover, in some instances, the normal protein diet used for
comparison, when corrected for body weight, gave only 0.77 g/
kg of protein; thus, in actuality, the "low-protein" diet and the
diet with a "normal protein" content did not differ greatly. In
my opinion, it is impressive, given such a small difference in
dietary protein, that it was still possible to show a significant
difference in the rate of urea nitrogen utilization for albumin
synthesis. In fact, for each micromole/hour of urea nitrogen
utilization in the normal volunteer, there were 10 micromoles/
hour in uremic subjects on normal protein diets and 15 micro-
moles/hour in patients on "low-protein diets." Indeed, the
authors could not help concluding that "in uremic subjects a
low protein diet seemed to promote utilization of urea nitrogen"
but judged that this urea nitrogen utilization was of only minor
nutritional significance [201. The point I would stress, however,
is that the diet employed in this study is not comparable to the
truly low protein diets that we [151, Giovannetti and Maggiore
[23], and Shaw et al [24] have proposed. The only conclusion I
would draw from the studies of Varcoe and coworkers is that if
one does not give a truly low protein diet, urea nitrogen
utilization still occurs but is no longer of great nutritional
significance.
The other "rigorous" investigation that seemingly refutes the
concept that urea nitrogen is utilized to a significant extent in
uremic patients on low-nitrogen diets was performed by Walser
[25]. Although Walser used an excellent method to investigate
urea metabolism in 13 uremic subjects, I think insufficient
attention was paid to their energy intake. In fact, in the
78 published report there is no information about the amount of
101.4 calories the patients were receiving. This issue is of crucial
importance because a high calorie intake is required to prevent
54.6 catabolism when nitrogen intake is very low and when amino
93.6 acid mixtures are the predominant source of exogenous nitro-
31.2 gen, as was the case in the Walser study. If the caloric intake
was similar to that employed by Walser's group in related
85:8 studies published at about the same time [26], one would
39 surmise that the intake was about 25 cal/kg body weight. This
caloric intake is perhaps one-half that required to prevent
catabolism under these circumstances and, in my view, casts
serious doubt on the conclusions drawn from that study.
In summary, had protein been properly restricted in the
patients of Varcoe and coworkers [20, 21], I think a much larger
incorporation of urea nitrogen would have been found, and the
results would have been in keeping with other studies [23, 24,
27—39]. Likewise, had the patients studied by Walser been given
an adequate energy intake, I believe his results would have
been different.
As noted earlier, adequate nutrition can be maintained even
when the ingestion of high-biologic-value protein is reduced to
0.17 g/kg body weight, a value far below the accepted minimum
of 0.5 g/kg body weight; the proviso is that an adequate source
of exogenous ammonium nitrogen must be available to ensure
that total nitrogen intake is equivalent to that provided by 0.5 g
of protein/kg body weight. Our work has shown that 2 g of
nitrogen in the form of essential amino acids can maintain
uremic patients in positive balance as long as they are azotemic
[15]. When azotemia resolves, the same nitrogen intake has to
be supplemented by oral urea to reestablish positive nitrogen
balance. This finding indicates that an exogenous source of
nonspecific nitrogen is required by normal individuals and by
nonazotemic patients with renal disease, but not by uremic
patients. It should be noted that the intake of 2 g of nitrogen for
a 70kg patient corresponds exactly to an equivalent of 0.17 g/kg
body weight of protein and suggests a perfect agreement
between the Kofranyi and Jekat data in healthy individuals [101
and our data in uremic subjects. However, because we used a
mixture containing mostly DL-amino acids and because, for the
most part, only L-amino acids can be utilized by humans, it is
likely that in uremia, ingestion of even less than 0.17 g/kg body
weight of protein rich in essential amino acids is sufficient to
maintain nitrogen balance; this expectation was recently con-
firmed in patients with minimal nitrogen intake [40]. Virtually
the same results can be obtained whether one uses essential
amino acids as such or a low-protein diet rich in essential amino
acids.
The low-protein diet that we advocate supplies 188 kj/kg body
weight and contains, for a 70 kg patient, 25 g of protein, most of
which is of high biologic value, that is, protein derived from
egg, milk, other dairy products, fish, rice, and meat. It is
important that vitamins and minerals be supplied as well. The
Mayo Clinic has prepared excellent collections of recipes for
high-biologic-value protein [41]. On such a diet, 85% of azote-
Relative
amount Adult Child Infant
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mic patients show a positive nitrogen balance [421 and have a
longer survival than do those taking a 40 g protein diet [431.
A persistent problem is getting patients to adhere to a low-
protein diet. A simple interview technique was rated as an
accurate method of assessing patients' adherence to their diets
[44]. A careful study revealed that 94% of patients cheated on
their diets [45]; it should be noted, however, that most of these
patients, as well as their relatives, were more interested in
treatment by dialysis and transplantation than a low-protein
diet. In the long run, the poor palatability of the diet causes
poor acceptance of it, and often the patient breaks the regimen
or shows signs of malnutrition. Malnutrition can ensue, there-
fore, as a consequence of progressive loss of interest in the diet
or, as we have pointed out [46], as an effect of increased protein
requirement during stress, infection, and the like. To prevent
malnutrition, we recently proposed a modulated nitrogen intake
for patients on low-protein diets, in which patients are allowed
to boost their protein intake twice weekly [471.
Let us now return to the patient under discussion today. He is
noteworthy both because he had been maintained for about a
decade on a low-protein diet and because the quality of his life
was quite good. Figure 1 illustrates that the patient's creatinine
clearance level was stable at about 25 mI/mm for approximately
2 years, fell to about 15 ml/min for 4 years, and then dropped to
about 10 mI/mm for more than 3 years. The diagnosis during this
10-year span has been 'stable" chronic renal failure; that is, the
patient has had a reasonably stable nephron population. Yet he
has developed neither hyperlipidemia, uremic osteodystrophy,
nor neuropathy. After spending 10 years on a low-protein diet,
he began treatment with dialysis therapy. He was not, there-
fore, an "early" dialysis patient [481, nor was he in "terminal"
renal failure; thus he did not experience the rapid deterioration
syndrome described in the past [49]. Dialysis was initiated when
his creatinine clearance fell to 3.9 mI/mm.
Because we do not know the nature of this patient's underly-
ing disease, we cannot conclude with certainty that his long
survival was a result of the low-protein diet. On the other hand,
it is hard to believe that the low-protein diet did any harm.
Questions and answers
DR. NIcoLAos E. MADIAs: It is well established that intro-
duction of a low-protein diet in a uremic patient decreases
nausea and vomiting and reduces the patient's fatigue. My
question is twofold. First, is there evidence that other manifes-
tations of uremia such as neuropathy, bleeding diathesis, pen-
carditis, osteodystrophy, and anemia are improved by such diets?
Second, is there solid evidence that introducing a low-protein
diet decreases the rate of subsequent nephron destruction?
DR. GI0RDAN0: Neuropathy, bleeding diathesis, pericarditis,
osteodystrophy, and anemia in an undialyzed patient are all
signs of advanced uremia, a stage of the disease in which
treatment with hemodialysis is preferable to a low-protein diet.
On the other hand, patients who have been on a low-protein diet
for a long time, but who still have no gastrointestinal symptoms,
enter the terminal stage of uremia with more severe anemia and
a more severe bleeding tendency and agitation than do terminal
uremic patients who have not been on a low-protein diet; these
patients manifest a sort of "bleeding-agitation syndrome" [49].
The answer to the second part of your question is no.
However, data from Ibels and coworkers indicate that dietary
restriction of phosphate, more than protein, decreases the rate
of destruction of nephrons in the rat [50]. So it is not clear
whether a low-protein diet is beneficial because of its low
protein content or its low phosphorus content.
DR. NATALE G. Dii SANTO (Department of Nephrology,
University of Naples): Dr. Giordano, it had been stated in the
early '60s that it was impossible to put a uremic patient in
positive nitrogen balance [51]. The patient you presented dem-
onstrates that positive nitrogen balance can be achieved and
maintained for years and that endogenous urea can be utilized
for protein synthesis. In light of these observations, should we
no longer think of uremia as a catabolic state?
DR. GI0RDAN0: The study you are citing was conducted in
patients with acute uremia. Patients suffering from acute renal
failure, as you know, differ from those with chronic uremia in
that they are inevitably catabolic, at times exceptionally so.
Because of these conditions, it is not possible for these patients
to attain positive nitrogen balance.
DR. MADIAs: What is your opinion about the role of keto-
acids in the dietary management of chronic renal failure?
DR. GI0RDAN0: The initial enthusiasm about the use of
ketoacids [18, 26] has been dampened by subsequent articles in
the literature [52—55]. In weighing the pros and cons [56], I
believe that currently there is neither any solid evidence that
ketoacids do something that amino acids cannot accomplish,
nor any convincing data that ketoacids do better than their
analogous amino acids. Therefore, work is still needed to take
full advantage of the theoretical superiority of non-nitrogenous
compounds substituting their analogous amino acids. It is
interesting to note that the same researchers who advocated the
use of ketoacids instead of essential amino acids recently
reported reducing dialysis frequency by using essential amino
acids and not ketoacid analogues [57].
DR. CAPASSO (First Faculty of Medicine, University of Na-
ples): Dr. Giordano, would you please elaborate on your
interpretation of the tyrosine/phenylalanine ratio in patients
with chronic renal disease?
DR. GI0RDAN0: There is relatively more phenylalanine and
less tyrosine in the plasma of uremic patients [58]. The tyrosine/
phenylalanine ratio is reduced not only in uremic patients on a
low protein intake but also in those ingesting normal or supra-
normal amounts of protein [59]. This fact is somewhat incon-
sistent with the interpretation that the low conversion of
tyrosine from phenylalanine is a symptom of malnutrition, as
found in kwashiorkor, which is characterized by a depressed
tyrosine/phenylalanine ratio [60]. A correlation between the
increase in serum creatinine and the decrease of the tyrosine/
phenylalanine ratio has been shown [591. Plasma levels of
phenylpyruvic acid increase in uremic patients following a
phenylalanine load [59, 611. All these data are consistent with
either a reduced activity of phenylalanine hydroxylase, an
enzyme that turns phenylalanine into tyrosine, or even with a
somewhat impaired transport of phenylalanine into cells [59,
61]. Lymphocytes from uremic patients exhibit the same re-
duced ratio of tyrosine to phenylalanine [58]; thus, this last
interpretation remains open.
DR. NICHOLAS FRANK (Department of Nephrology, Universi-
ty of Naples): What diet should be instituted in the uremic
infant or child in an effort to foster reasonable growth and
development?
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DR. GI0RDAN0: That is a very interesting question. The
problem is twofold for the child. In the uremic child, dietary
therapy is well accepted; it is known that children with chronic
renal failure show increased catabolism and reduced anabolism
and therefore do not thrive [62].
A low-protein diet and increased caloric intake are indispens-
able requirements for the treatment of chronic renal failure in
children. Fortification of the diet with an amino acid mixture
also has proved beneficial [63]. The low-protein diet should be
supplemented with any amount of essential nitrogen as long as
certain proportions among the various components are respect-
ed and imbalance avoided [64]. This nutritional approach can
sometimes prevent stunting [65].
DR. MADIAs: Do the amounts of protein and essential amino
acids you recommend in adults reflect minimum requirements?
If so, are they standard for any level of uremia?
DR. GI0RDAN0: When we use protein-containing diets in
patients who are severely azotemic, we refer to the classic
studies on minimum requirements; in patients with lesser
degrees of azotemia, we recommend a protein intake that is
higher than minimum requirements, a so-called 'safe intake."
Minimum requirement figures are obtained by the factorial
method and are based on an estimation of the various obligatory
losses (from integument and excreta). We use 49 mg/kg body
weight of nitrogen as a minimum figure [66]. For a 70 g male,
this means 21 g of protein a day. Taking into account individual
variability and the percentage of protein utilized, we approach
the safe intake for a normal adult male, which can be set at a
level of 75 mg/kg body weight of nitrogen, as shown in balance
studies on adults on mixed diets [67]. This corresponds to about
33 g of mixed protein as the daily safe intake for a 70 kg male. I
should clarify that the safe level of intake refers to the amount
of protein adequate for physiologic needs and necessary to
maintain health in almost all persons in a given group. Howev-
er, neither the minimum intake of 21 g of protein nor the safe
intake of 33 g takes into account the contribution to protein
synthesis that is made by retained nitrogen in the form of urea.
Thus, a 40 g protein diet for uremic patients is not a low-protein
diet.
Regarding amino acids, the amount we recommend reflects
the requirements for safe intake, in other words, figures that are
valid for nearly all people. To avoid adverse effects, which are
not infrequent during amino acid feedings [681, we must consid-
er the spectrum of amino acids and the relative amounts of each
compound.
Using threonine as a point of reference [53, 691 and taking
into account several features of the uremic state [58, 70], we
have suggested use of the pattern of essential amino acids
shown in Table 2 [53].
Of course, the dietitian in our program plays a strategic role
in the managemetit of uremic patients who are on a low-protein
diet. It is impossible to get along without a well-trained dieti-
tian. Indeed, patient compliance with the diet is, in my view,
almost directly proportional to the skill of the dietitian.
DR. MADIAS: As you know, a substantial proportion of
patients with chronic renal failure have hypertrig!yceridemia,
type-IV hyperlipoproteinemia, and glucose intolerance. Does a
low-protein diet rich in carbohydrates and fats tend to make
these metabolic abnormalities worse? If so, are there any
strategies, such as isocaloric substitution of unsaturated fats for
carbohydrate, that could help prevent such changes? My ques-
tion pertains not only to patients on dialysis or to those with
severe uremia, but to all patients with chronic renal failure.
DR. GI0RDAN0: If the patient has a high triglyceride level
and/or type-IV hyperlipoproteinemia before the diet is started,
dietary management itself may improve the hyperlipemia and
not worsen it [71]. If, on the other hand, the patient develops
high triglyceride levels and/or type-IV hyperlipoproteinemia
while on the diet, then the diet should be changed so that
carbohydrates supply 35% of the energy, and fats supply 55%
[72]. A small proportion of the dietary fat should be in the form
of unsaturated fatty acids. One word of caution: lipid values can
fluctuate for a long time before reaching a plateau on a given
diet, and thus one should wait 8 months or more before making
a change [731.
DR. MADIAS: Renal acid excretion in patients with chronic.
renal failure characteristically falls short of endogenous acid
production and results in positive hydrogen ion balance and a
reduction in plasma bicarbonate concentration. Does the intro-
duction of a low-protein diet, by dampening catabolism, im-
prove hydrogen ion balance and raise plasma bicarbonate?
DR. GIORDANO: At the beginning of the investigation of low-
protein diets, no amelioration of acidosis was reported. Rather,
many patients became increasingly acidotic, mainly as a result
of the supplemental methionine [34]. We now have data indicat-
ing that blood pH and plasma bicarbonate concentrations do
improve in patients maintained on the diet for many years [74].
DR. MADIA5: Do you modify the low-protein diet in patients
with heavy proteinuria or in patients who are receiving steroids?
DR. GI0RDAN0: Yes. For each gram of protein lost in the
urine, we add 1.43 g to the diet. This ratio is based on an
estimate of 70% net protein utilization.
Reprint requests to Dr. C. Giordano, Policlinico Cappella Con giani,
Padiglione 17, Via Pansini, 80131, Naples, Italy
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